Disclosure under Regulation 44 (3) of SEBI (LODR) Regulations, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Godavari Drugs Limited held its Extra-Ordinary General Meeting on February 12, 2026 at 11:00 AM via Video Conference. Two special resolutions were put to vote and both were passed with overwhelming majority. Resolution 1 approved the issue of equity shares on a preferential basis to promoters and non-promoters for cash consideration, and Resolution 2 approved the issue of convertible warrants on a preferential basis to promoters for cash consideration. Out of 7,530,500 outstanding shares, 4,360,729 votes (57.91%) were polled, with 99.99% voting in favour of both resolutions (only 9 votes against each). The promoter group was interested in both resolutions. The scrutinizer was Ms. Vidya Harkut of VSS & Associates.
Shareholders have approved preferential share and warrant issuances to promoters and non-promoters, which will bring fresh capital into the company but may result in dilution for existing public shareholders. The near-unanimous approval suggests strong backing for the fundraising plan.